Sonoma Pharmaceuticals (SNOA) Net Income towards Common Stockholders: 2010-2012
Historic Net Income towards Common Stockholders for Sonoma Pharmaceuticals (SNOA) over the last 3 years, with Dec 2012 value amounting to -$1.9 million.
- Sonoma Pharmaceuticals' Net Income towards Common Stockholders rose 24.93% to -$1.9 million in Q4 2012 from the same period last year, while for Dec 2012 it was -$5.4 million, marking a year-over-year increase of 24.56%. This contributed to the annual value of -$7.4 million for FY2012, which is 6.50% up from last year.
- According to the latest figures from Q4 2012, Sonoma Pharmaceuticals' Net Income towards Common Stockholders is -$1.9 million, which was down 74.45% from -$1.1 million recorded in Q3 2012.
- Sonoma Pharmaceuticals' Net Income towards Common Stockholders' 5-year high stood at -$617,000 during Q2 2012, with a 5-year trough of -$2.5 million in Q4 2011.
- In the last 3 years, Sonoma Pharmaceuticals' Net Income towards Common Stockholders had a median value of -$1.7 million in 2012 and averaged -$1.7 million.
- The largest annual percentage gain for Sonoma Pharmaceuticals' Net Income towards Common Stockholders in the last 5 years was 71.63% (2012), contrasted with its biggest fall of 27.59% (2012).
- Sonoma Pharmaceuticals' Net Income towards Common Stockholders (Quarterly) stood at -$2.2 million in 2010, then fell by 16.57% to -$2.5 million in 2011, then increased by 24.93% to -$1.9 million in 2012.
- Its last three reported values are -$1.9 million in Q4 2012, -$1.1 million for Q3 2012, and -$617,000 during Q2 2012.